Hugh Jackman, the Australian actor best known for his portrayal of Wolverine in the X-Men film series, has been diagnosed with a form of skin cancer. He has been an active advocate for early detection and prevention of skin cancer. In November 2013, Jackman shared a photo on social media of his bandaged nose, announcing that he had a cancerous growth removed from his face. He urged his fans and followers to use sunscreen and get regular skin checks from a dermatologist. Since then, he has undergone several more surgeries to remove cancerous cells from his skin. Jackman has used his public platform to raise awareness about the dangers of skin cancer and the importance of protecting oneself from harmful UV rays.
Hugh Jackman has had several skin cancer lesions removed from his nose over the years. In 2014, his publicist announced that Jackman had been treated for basal cell carcinoma for the third time in 12 months. The actor first underwent treatment in 2013, when doctors identified the first cancerous lesion on his nose.
Basal cell carcinoma is a type of skin cancer that often appears as a small, raised, smooth or pearly bump on the face, ears or neck or other areas frequently exposed to the sun. The treatment for this type of skin cancer typically involves removing the lesion surgically. In Jackman’s case, the lesion was removed by a dermatologist using MOHS surgery, which involves the removal of skin tissue in layers until no more cancer cells are found. The procedure is known for being highly effective and providing the second highest chance of cure with some likely scarring.
Hugh Jackman was skin cancer lesion was surgically removed by a dermatologist using the traditional MOHS surgery technique. MOHS has long been the primary method that dermatologists approach treatment of basil cell carcinoma. MOHS which involves the removal of skin tissue in layers until no more cancer cells are found.
Another approach to removing Hugh Jackman’s type of skin cancer is through Superficial Radiation Therapy, or SRT. It is also a long-established technique that uses pinpoint focused radiation to remove the skin cancer without any cutting. The downside is that it takes several 2-5 minute sessions over the course of 4 weeks to complete the treatment. It offers an option that avoids surgical excision and potential scarring.
Traditional MOHS practitioners may not have access to a Superficial Radiation Therapy device which can cost upwards of $200,000. Additionally, many dermatologists may have used the MOHS technique for many years and not have an interest in adopting another method. Any patient with potential skin cancer should consult with doctor about all available treatment options.
If someone suspects that they have skin cancer, the first step is to schedule an appointment with a dermatologist. They are experts in detecting and diagnosing skin cancer. During the appointment, the dermatologist will examine the skin closely and may take a tissue sample for a biopsy in case a suspicious mole is found. The biopsy results will help determine whether the mole is cancerous or not.
If a mole is confirmed to be cancerous, the dermatologist will discuss treatment options with the affected person. The treatment option usually depends on the type of skin cancer, the size, and location of the tumor. Treatment options may include surgical excision, radiation therapy, or chemotherapy. It is also important for someone who suspects they have skin cancer to practice good sun protection habits, such as wearing protective clothing and sunscreen daily and avoiding prolonged sun exposure. Overall, early detection and treatment of skin cancer can significantly improve a person’s chances of a positive outcome and prevent potential complications.